Methaemoglobinaemia in the newborn infant

Area of Science:

• Hematology
• Pediatric Medicine
• Clinical Toxicology

Background:

• Methaemoglobinaemia is a rare condition where oxidized hemoglobin iron prevents oxygen binding.
• Severe cases result in hypoxemia and can be fatal.
• It can be acquired through oxidant exposure or inherited via hemoglobinopathies or enzyme defects.

Purpose of the Study:

• To review the pathophysiology, risk factors, and clinical approach to methaemoglobinaemia.
• To highlight the increased risk in newborn infants.
• To emphasize the importance of early diagnosis and treatment.

Main Methods:

• Literature review of methaemoglobinaemia.
• Discussion of acquired and inherited causes.
• Analysis of clinical presentation and management strategies.

Main Results:

• Newborns are at higher risk due to transient enzyme deficiency and fetal hemoglobin properties.
• Clinical approach is similar across age groups, guided by symptom severity.
• Diagnosis is straightforward, and treatment is effective.

Conclusions:

• A high index of clinical suspicion is vital for potentially life-saving interventions.
• Prompt diagnosis and effective treatment can prevent mortality.
• Understanding the mechanisms and risk factors aids in managing this condition.